ROMITI, ADRIANA
ROMITI, ADRIANA
DIPARTIMENTO DI MEDICINA CLINICA E MOLECOLARE
17) Follow-up of intestinal metaplasia in the stomach: When, how and why.
2012 A., Zullo; C., Hassan; Romiti, Adriana; M., Giusto; C., Guerriero; R., Lorenzetti; S. M., Campo; Tomao, Silverio
5-Fluorouracil degradation rate could predict toxicity in stages II-III colorectal cancer patients undergoing adjuvant FOLFOX
2016 Onesti, CONCETTA ELISA; Botticelli, Andrea; LA TORRE, Marco; Borro, Marina; Gentile, Giovanna; Romiti, Adriana; Lionetto, Luana; Petremolo, Antonella; Occhipinti, Mario; Roberto, Michela; Falcone, Rosa; Simmaco, Maurizio; Marchetti, Paolo; Mazzuca, Federica
A rare case of palatin tonsillar metastasis from small cell lung cancer
2016 D'Antonio, Chiara; Lombardini, Alberto; Onesti, CONCETTA ELISA; Falcone, Rosa; Romiti, Adriana; Lombardi, Marianna; Lauro, Salvatore; Marchetti, Paolo
Arterial thrombotic events and acute coronary syndromes with cancer drugs: Are growth factors the missed link? What both cardiologist and oncologist should know about novel angiogenesis inhibitors
2013 E., Conti; Romiti, Adriana; Musumeci, Maria Beatrice; Passerini, Jasmine; L., Zezza; Mastromarino, Vittoria; C., D'Antonio; Marchetti, Paolo; Paneni, Francesco; Autore, Camillo; Volpe, Massimo
Association between proton-pump inhibitors (PPI) and metronomic capecitabine (MCAP) as salvage treatment for patients with advanced gastro-intestinal tumoursa. A randomized phase II study
2015 Milano, Annalisa; D'Antonio, Chiara; Roberto, Michela; Falcone, Rosa; DI PIETRO, FRANCESCA ROMANA; Durante, Valeria; Romiti, Adriana; Marchetti, P.
Bevacizumab plus chemotherapy in metastatic colorectal cancer patients treated in clinical practice.
2012 Luigi, Rossi; Enzo, Veltri; Angelo, Zullo; Federica, Zoratto; Maria, Colonna; Marisa Di, Seri; Flavia, Longo; Marcella, Mottolese; Diana, Giannarelli; Ruco, Luigi; Romiti, Adriana; Barucca, Viola; Daniela, Adua; Tomao, Silverio
cAn cArdio-vAsculAr toxicity And bmi evAluAtions predict outcomes in pAtients treAted with chemotherApy plus bevAcizumAb for metAstAtic colorectAl cAncer?
2013 Milano, Annalisa; D'Antonio, Chiara; Lombardini, Alberto; Durante, Valeria; Romiti, Adriana; Sarcina, Ida; Falcone, Rosa; Roberto, Michela; Marchetti, Paolo
Circulating tumor cells count predicts survival in colorectal cancer patients.
2014 Romiti, Adriana; Raffa, Salvatore; R., Di Rocco; Roberto, Michela; Milano, Annalisa; A., Zullo; Leone, Laura; Ranieri, Danilo; F., Mazzetta; E., Medda; I., Sarcina; Barucca, Viola; C., D'Antonio; V., Durante; Ferri, Mario; Torrisi, Maria Rosaria; Marchetti, Paolo
Combination therapy of high-dose rabeprazole plus metronomic capecitabine in advanced gastrointestinal cancer: a randomized phase II trial
2020 Roberto, Michela; Romiti, Adriana; Mazzuca, Federica; Milano, Annalisa; D'Antonio, Chiara; Luana, Lionetto; Falcone, Rosa; Strigari, Lidia; Simmaco, Maurizio; Fais, Stefano; Marchetti, Paolo
Complete Regression of a Non-small Cell Lung Cancer Choroidal Metastasis with Intravitreal Bevacizumab
2012 C., D'Antonio; Viterbo, Antonella; Romiti, Adriana; MAURIZI ENRICI, Maurizio; Lauro, Salvatore; Marchetti, Paolo
Continuous, low-dose capecitabine for patients with recurrent colorectal cancer
2015 Romiti, Adriana; Onesti, Concetta Elisa; Roberto, Michela; Barucca, Viola; Tomao, Silverio; D’Antonio, Chiara; Durante, Valeria; Milano, Annalisa; Falcone, Rosa; Di Rocco, Roberta; Righini, Riccardo; Marchetti, Paolo
Current achievements and future perspectives of metronomic chemotherapy
2017 Romiti, Adriana; Falcone, Rosa; Roberto, Michela; Marchetti, Paolo
Degradation rate of 5-fluorouracil in metastatic colorectal cancer. A new predictive outcome biomarker?
2016 Botticelli, Andrea; Borro, Marina; Onesti, CONCETTA ELISA; Strigari, Lidia; Gentile, Giovanna; Cerbelli, Bruna; Romiti, Adriana; Occhipinti, Mario; Sebastiani, Claudia; Lionetto, Luana; Marchetti, Luca; Simmaco, Maurizio; Marchetti, Paolo; Mazzuca, Federica
Evaluation of 5-fluorouracil degradation rate and pharmacogenetic profiling to predict toxicity following adjuvant capecitabine
2017 Roberto, Michela; Romiti, Adriana; Botticelli, Andrea; Mazzuca, Federica; Lionetto, Luana; Gentile, Giovanna; Paris, Ida; Falcone, Rosa; Bassanelli, Maria; DI PIETRO, FRANCESCA ROMANA; Onesti, CONCETTA ELISA; Anselmi, Elisabetta; Macrini, Serena; Simmaco, Maurizio; Marchetti, Paolo
Evolving treatments for advanced gastric cancer: appraisal of the survival trend
2016 Roberto, Michela; Romiti, Adriana; Onesti, CONCETTA ELISA; Zullo, Angelo; Falcone, Rosa; Marchetti, Paolo
Exploring the Prognostic Role of Microsatellite Instability in Patients With Stage II Colorectal Cancer: A Systematic Review and Meta-Analysis
2016 Romiti, Adriana; Rulli, Eliana; Pilozzi, Emanuela; Gerardi, Chiara; Roberto, Michela; Legramandi, Lorenzo; Falcone, Rosa; Pacchetti, Ilaria; Marchetti, Paolo; Floriani, Irene
Focus on genetic and epigenetic events of colorectal cancer pathogenesis: implications for molecular diagnosis
2014 Zoratto, Federica; Rossi, Luigi; Verrico, Monica; Papa, Anselmo; Basso, Enrico; Angelo, Zullo; Luigi, Tomao; Romiti, Adriana; LO RUSSO, Giuseppe; Tomao, Silverio
Gastric mucosa alterations in first-degree relatives of gastric cancer patients
2005 Romiti, Adriana; A., Zullo; Tomao, Silverio; C., Hassan; I., Sarcina; V., De Francesco; E., Ierardi; Tomao, Federica; Vecchione, Aldo; S., Morini
High-doses of proton pump inhibitors in refractory gastro-intestinal cancer: A case series and the state of art
2016 Falcone, Rosa; Roberto, Michela; D'Antonio, Chiara; Romiti, Adriana; Milano, Annalisa; Onesti, CONCETTA ELISA; Marchetti, Paolo; Fais, Stefano
Impact of tumor site on the prognosis of small bowel adenocarcinoma
2019 Falcone, Rosa; Romiti, Adriana; Filetti, Marco; Roberto, Michela; Righini, Riccardo; Botticelli, Andrea; Pilozzi, Emanuela; Ghidini, Michele; Pizzo, Claudio; Mazzuca, Federica; Marchetti, Paolo
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| 17) Follow-up of intestinal metaplasia in the stomach: When, how and why. | 2012 | A., Zullo; C., Hassan; Romiti, Adriana; M., Giusto; C., Guerriero; R., Lorenzetti; S. M., Campo; Tomao, Silverio | |
| 5-Fluorouracil degradation rate could predict toxicity in stages II-III colorectal cancer patients undergoing adjuvant FOLFOX | 2016 | Onesti, CONCETTA ELISA; Botticelli, Andrea; LA TORRE, Marco; Borro, Marina; Gentile, Giovanna; Romiti, Adriana; Lionetto, Luana; Petremolo, Antonella; Occhipinti, Mario; Roberto, Michela; Falcone, Rosa; Simmaco, Maurizio; Marchetti, Paolo; Mazzuca, Federica | |
| A rare case of palatin tonsillar metastasis from small cell lung cancer | 2016 | D'Antonio, Chiara; Lombardini, Alberto; Onesti, CONCETTA ELISA; Falcone, Rosa; Romiti, Adriana; Lombardi, Marianna; Lauro, Salvatore; Marchetti, Paolo | |
| Arterial thrombotic events and acute coronary syndromes with cancer drugs: Are growth factors the missed link? What both cardiologist and oncologist should know about novel angiogenesis inhibitors | 2013 | E., Conti; Romiti, Adriana; Musumeci, Maria Beatrice; Passerini, Jasmine; L., Zezza; Mastromarino, Vittoria; C., D'Antonio; Marchetti, Paolo; Paneni, Francesco; Autore, Camillo; Volpe, Massimo | |
| Association between proton-pump inhibitors (PPI) and metronomic capecitabine (MCAP) as salvage treatment for patients with advanced gastro-intestinal tumoursa. A randomized phase II study | 2015 | Milano, Annalisa; D'Antonio, Chiara; Roberto, Michela; Falcone, Rosa; DI PIETRO, FRANCESCA ROMANA; Durante, Valeria; Romiti, Adriana; Marchetti, P. | |
| Bevacizumab plus chemotherapy in metastatic colorectal cancer patients treated in clinical practice. | 2012 | Luigi, Rossi; Enzo, Veltri; Angelo, Zullo; Federica, Zoratto; Maria, Colonna; Marisa Di, Seri; Flavia, Longo; Marcella, Mottolese; Diana, Giannarelli; Ruco, Luigi; Romiti, Adriana; Barucca, Viola; Daniela, Adua; Tomao, Silverio | |
| cAn cArdio-vAsculAr toxicity And bmi evAluAtions predict outcomes in pAtients treAted with chemotherApy plus bevAcizumAb for metAstAtic colorectAl cAncer? | 2013 | Milano, Annalisa; D'Antonio, Chiara; Lombardini, Alberto; Durante, Valeria; Romiti, Adriana; Sarcina, Ida; Falcone, Rosa; Roberto, Michela; Marchetti, Paolo | |
| Circulating tumor cells count predicts survival in colorectal cancer patients. | 2014 | Romiti, Adriana; Raffa, Salvatore; R., Di Rocco; Roberto, Michela; Milano, Annalisa; A., Zullo; Leone, Laura; Ranieri, Danilo; F., Mazzetta; E., Medda; I., Sarcina; Barucca, Viola; C., D'Antonio; V., Durante; Ferri, Mario; Torrisi, Maria Rosaria; Marchetti, Paolo | |
| Combination therapy of high-dose rabeprazole plus metronomic capecitabine in advanced gastrointestinal cancer: a randomized phase II trial | 2020 | Roberto, Michela; Romiti, Adriana; Mazzuca, Federica; Milano, Annalisa; D'Antonio, Chiara; Luana, Lionetto; Falcone, Rosa; Strigari, Lidia; Simmaco, Maurizio; Fais, Stefano; Marchetti, Paolo | |
| Complete Regression of a Non-small Cell Lung Cancer Choroidal Metastasis with Intravitreal Bevacizumab | 2012 | C., D'Antonio; Viterbo, Antonella; Romiti, Adriana; MAURIZI ENRICI, Maurizio; Lauro, Salvatore; Marchetti, Paolo | |
| Continuous, low-dose capecitabine for patients with recurrent colorectal cancer | 2015 | Romiti, Adriana; Onesti, Concetta Elisa; Roberto, Michela; Barucca, Viola; Tomao, Silverio; D’Antonio, Chiara; Durante, Valeria; Milano, Annalisa; Falcone, Rosa; Di Rocco, Roberta; Righini, Riccardo; Marchetti, Paolo | |
| Current achievements and future perspectives of metronomic chemotherapy | 2017 | Romiti, Adriana; Falcone, Rosa; Roberto, Michela; Marchetti, Paolo | |
| Degradation rate of 5-fluorouracil in metastatic colorectal cancer. A new predictive outcome biomarker? | 2016 | Botticelli, Andrea; Borro, Marina; Onesti, CONCETTA ELISA; Strigari, Lidia; Gentile, Giovanna; Cerbelli, Bruna; Romiti, Adriana; Occhipinti, Mario; Sebastiani, Claudia; Lionetto, Luana; Marchetti, Luca; Simmaco, Maurizio; Marchetti, Paolo; Mazzuca, Federica | |
| Evaluation of 5-fluorouracil degradation rate and pharmacogenetic profiling to predict toxicity following adjuvant capecitabine | 2017 | Roberto, Michela; Romiti, Adriana; Botticelli, Andrea; Mazzuca, Federica; Lionetto, Luana; Gentile, Giovanna; Paris, Ida; Falcone, Rosa; Bassanelli, Maria; DI PIETRO, FRANCESCA ROMANA; Onesti, CONCETTA ELISA; Anselmi, Elisabetta; Macrini, Serena; Simmaco, Maurizio; Marchetti, Paolo | |
| Evolving treatments for advanced gastric cancer: appraisal of the survival trend | 2016 | Roberto, Michela; Romiti, Adriana; Onesti, CONCETTA ELISA; Zullo, Angelo; Falcone, Rosa; Marchetti, Paolo | |
| Exploring the Prognostic Role of Microsatellite Instability in Patients With Stage II Colorectal Cancer: A Systematic Review and Meta-Analysis | 2016 | Romiti, Adriana; Rulli, Eliana; Pilozzi, Emanuela; Gerardi, Chiara; Roberto, Michela; Legramandi, Lorenzo; Falcone, Rosa; Pacchetti, Ilaria; Marchetti, Paolo; Floriani, Irene | |
| Focus on genetic and epigenetic events of colorectal cancer pathogenesis: implications for molecular diagnosis | 2014 | Zoratto, Federica; Rossi, Luigi; Verrico, Monica; Papa, Anselmo; Basso, Enrico; Angelo, Zullo; Luigi, Tomao; Romiti, Adriana; LO RUSSO, Giuseppe; Tomao, Silverio | |
| Gastric mucosa alterations in first-degree relatives of gastric cancer patients | 2005 | Romiti, Adriana; A., Zullo; Tomao, Silverio; C., Hassan; I., Sarcina; V., De Francesco; E., Ierardi; Tomao, Federica; Vecchione, Aldo; S., Morini | |
| High-doses of proton pump inhibitors in refractory gastro-intestinal cancer: A case series and the state of art | 2016 | Falcone, Rosa; Roberto, Michela; D'Antonio, Chiara; Romiti, Adriana; Milano, Annalisa; Onesti, CONCETTA ELISA; Marchetti, Paolo; Fais, Stefano | |
| Impact of tumor site on the prognosis of small bowel adenocarcinoma | 2019 | Falcone, Rosa; Romiti, Adriana; Filetti, Marco; Roberto, Michela; Righini, Riccardo; Botticelli, Andrea; Pilozzi, Emanuela; Ghidini, Michele; Pizzo, Claudio; Mazzuca, Federica; Marchetti, Paolo |